Finnvera Venture Capital logo

Finnvera Venture Capital

Europe, Eastern Finland, Finland, Kuopio

Description

Finnvera Venture Capital, operating primarily through its dedicated venture capital arm, Seed Fund Vera Ltd., is a key player in the early-stage funding landscape of Finland. As a specialized financing company wholly owned by the State of Finland, its mandate extends beyond purely commercial returns to fostering innovation and economic growth within the country. Seed Fund Vera Ltd. focuses on direct equity investments in nascent enterprises that demonstrate significant potential for high growth and international expansion.

The firm targets companies with innovative products or services, robust management teams, and clear ambitions for global market penetration. Seed Fund Vera's investment strategy is characterized by its collaborative approach; it consistently co-invests alongside other private investors, aiming to catalyze larger funding rounds for promising startups. A typical first cheque from Seed Fund Vera ranges from approximately $108,000 to $540,000 (equivalent to EUR 0.1 million to EUR 0.5 million), representing a minority stake in the portfolio companies.

These initial investments are often part of larger financing rounds, which commonly fall within the range of $540,000 to $2.16 million (EUR 0.5 million to EUR 2 million) in total capital raised. By providing crucial seed and early-stage capital, Finnvera Venture Capital, through Seed Fund Vera, plays a vital role in de-risking early-stage ventures and attracting further private investment into the Finnish startup ecosystem. Its state-backed nature provides a stable and strategic source of capital for companies that might otherwise struggle to secure funding in their initial phases, thereby supporting the development of a vibrant and competitive entrepreneurial environment in Finland.

Investor Profile

Finnvera Venture Capital has backed more than 91 startups, with 2 new investments in the last 12 months alone. The firm has led 15 rounds, about 16% of its total and boasts 19 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in Finland, United States, Switzerland.
  • Strong thematic focus on Software, Biotechnology, Health Care.
  • Typical check size: $108K – $540K.

Stage Focus

  • Seed (37%)
  • Series Unknown (30%)
  • Series A (16%)
  • Debt Financing (8%)
  • Series B (4%)
  • Angel (2%)
  • Post Ipo Debt (2%)

Country Focus

  • Finland (92%)
  • United States (5%)
  • Switzerland (1%)
  • Lithuania (1%)

Industry Focus

  • Software
  • Biotechnology
  • Health Care
  • Information Technology
  • Enterprise Software
  • Manufacturing
  • Computer
  • Mobile
  • Medical
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Finnvera Venture Capital frequently co-invest with?

Business Finland
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 8
Lifeline Ventures
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 6
Nordea
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 5
Finnish Climate Fund
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 3
VTT Ventures
Europe, Southern Finland, Finland, Espoo
Co-Investments: 5
Heartcore Capital
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
Tesi
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 3
VNT Management
Europe, Western Finland, Finland, Vaasa
Co-Investments: 3
Inventure
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 4

Which angels does Finnvera Venture Capital often collaborate with?

PK
Europe, Southern Finland, Finland, Espoo
Shared Deals: 1
RS
Europe, Southern Finland, Finland, Helsinki
Shared Deals: 1
SI
North America, Colorado, United States, Denver
Shared Deals: 1
MW
Europe, Southern Finland, Finland, Tuusula
Shared Deals: 1
Shared Deals: 1
RK
Europe, Oulu, Finland, Oulu
Shared Deals: 1
PP
Europe, Southern Finland, Finland, Helsinki
Shared Deals: 1
AK
Europe, Southern Finland, Finland, Lappeenranta
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Finnvera Venture Capital?

Volare

Uusimaa, Southern Finland, Finland

Circular economy - Upcycle industrial food waste into high quality protein, oil and fertilizer ingredients

Food and Beverage
Series UnknownMay 27, 2025
Amount Raised: $29,642,770
AISTI

Jyväskylä, Western Finland, Finland

AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free.

Building MaterialConstruction
Debt FinancingDec 12, 2024
Amount Raised: $14,139,294
Nexstim

Helsinki, Southern Finland, Finland

Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation.

BiotechnologyHealth CareHealth DiagnosticsMedical DeviceTherapeutics
Post Ipo DebtJun 27, 2024
Amount Raised: $1,605,667
Enifer

Espoo, Southern Finland, Finland

Enifer is a mycoprotein company that produces a fungal fermentation product to upcycle agrifood industry byproducts.

BiotechnologyFood and BeverageLife Science
Debt FinancingMay 23, 2024
Amount Raised: $9,730,561
Eevia Health

Seinäjoki, Western Finland, Finland

Eevia Health is a Finnish-Norwegian life science company.

BiotechnologyDietary SupplementsNatural ResourcesOrganic
Post Ipo DebtSep 27, 2023
Amount Raised: $520,013
Mjuk

Vantaa, Southern Finland, Finland

Marketplace for pre-owned, unique design furniture

Marketplace
Debt FinancingSep 12, 2023
Amount Raised: $537,660
Nordcloud

Helsinki, Southern Finland, Finland

Helping enterprises leverage the public cloud to transform their business.

Cloud ComputingInformation ServicesSoftware
Series AFeb 13, 2019
Amount Raised: $22,530,997
Enfuce

Espoo, Southern Finland, Finland

Enfuce is a fintech company that provides various financial services, including payment and card issuing solutions.

BankingFinancial ServicesFinTechPayments
Debt FinancingFeb 13, 2019
Amount Raised: $5,632,749
Aurealis Pharma

Kuopio, Eastern Finland, Finland

Aurealis Pharma is a biopharmaceutical company.

BiotechnologyHealth CareMedicalPharmaceutical
Series BFeb 12, 2019
Amount Raised: $7,752,393
TrademarkNow

New York, New York, United States

TrademarkNow™ is a legal technology powerhouse specializing in intellectual property law.

ConsultingEnterprise SoftwareInformation ServicesLegalReal EstateSoftware
Debt FinancingOct 3, 2017
Amount Raised: $2,349,591